Abstract:The investigation of the role of high glucose in adipocyte differentiation has an important conceptual implication. It can explain the metabolic dysregulation of obesity through the direct link between hyperglycemia and increase in adiposity. In the article entitled "An in vitromodel to probe the regulation of adipocyte differentiation under hyperglycemia," Shilpa et al. [1] reported that 105 mM high glucose inhibited differentiation of adipocyte and stimulated proliferation of preadipocyte. This study is of great interest in that very high glucose enhanced the risk of adiposity in 3T3-L1 cells. This concept is also demonstrated in other cell types. High glucose drives the differentiation of stem cells into adipocytes by increasing the expression of adipocyte specific proteins such as SREBP-1C, GLUT-4, and PPAR-γ [2]. Also high glucose activates an adipogenic differentiation in pancreatic β-cells. Besides, this study well agrees with many previous reports about an important role for protein kinase C (PKC) in diabetes and in adipogenesis. PKC appears to be involved in oxidative stress. Recently, PKC β has been found to recruit the 66-Kd Shc which triggers reactive oxygen species (ROS) production [3]. However, this study has some points to be discussed. First, the 105 mM (1,890 mg/dL) glucose concentration is not a physiologic concentration found in human except in hyperosmolar hyperglycemic state. Thus, it might be a stretch to argue that the effect of very high glucose concentration such as 105 mM on the adipogenesis can explain the pathogenesis of obesity. While 25 mM concentration of glucose was used as a control, it is already a high concentration which is somewhat similar to diabetic condition. Chuang et al. [4] demonstrated that 25 mM glucose condition enhanced adipogenesis and lipid accumulation in mesenchymal stem cells compared with the condition of 5.5 mM glucose. Perhaps the reason why they used 25 mM glucose as a control is that it is the glucose concentration employed at a conventional protocol of differentiation of 3T3L1 cell is 25 mM at all stages. However, if the author used the 5 to 6 mM glucose as a control, it would be more acceptable design explaining the effect of chronic hyperglycemia condition on adipogenesis. Lin et al. [5] studied about whether 4 mM of glucose could differentiate 3T3L1 cell. They showed smaller lipid droplets in oil red O stain and, more insulin sensitive signaling in phosphorylation of Akt under 4 mM glucose condition. The 25 mM glucose induced insulin resistance and increased ROS, proinflammatory cytokine, and resistin gene expression, even though larger lipid droplets was observed than at 4 mM glucose condition. Second, 105 mM glucose has high osmolarity, which can induce osmotic stress. There is a need for mannitol control to exclude the effect of high osmolarity. If there is a difference between the effect of 105 mM glucose versus mannitol control, it can clearly demonstrate that whether the increase of oxidative stress, cytokine gene expression, nuclear factor-κB, or tumor necrosis factor-α, is due to very high concentration of glucose itself or due to high osmolarity.

Experimenting with the family in the newborn period: a commentary.

O-GlcNAcylation Involvement in High Glucose-Induced Cardiac Hypertrophy Via ERK1/2 and Cyclin D2

The signal transduction pathway of PKC/NF-κB/c-fos may be involved in the influence of high glucose on the cardiomyocytes of neonatal rats

Skeletal Muscle TRIB3 Mediates Glucose Toxicity in Diabetes and High- Fat Diet–Induced Insulin Resistance

The signal transduction pathway of PKC/NF-kappa B/c-fos may be involved in the influence of high glucose on the cardiomyocytes of neonatal rats.

High Glucose Conditions Suppress the Function of Bone Marrow-Derived Endothelial Progenitor Cells Via Inhibition of the Enos-Caveolin-1 Complex.

Interactions between myoblasts and macrophages under high glucose milieus result in inflammatory response and impaired insulin sensitivity

In vivo effects of focused shock waves on tumor tissue visualized by fluorescence staining techniques.

High Glucose Reduces Hepatic Glycogenesis by Suppression of Microrna-152

Glucotoxicity and Α Cell Dysfunction: Involvement of the PI3K/Akt Pathway in Glucose-Induced Insulin Resistance in Rat Islets and Clonal Αtc1-6 Cells.

Glucose Sensing by Skeletal Myocytes Couples Nutrient Signaling to Systemic Homeostasis.

High Glucose Induces the Aging of Mesenchymal Stem Cells Via Akt/mTOR Signaling

Constitutively active mutant GS alpha (G225T) and null-mutant G alpha i-2 (G203T) induce primitive endoderm from stem cells.

1303-P: Decreased Hepatic HMGB1 in Type 2 Diabetes Increases Mitochondrial Glucose Uptake by Regulating Insulin/AKT Signaling

O-GlcNAcase deficiency suppresses skeletal myogenesis and insulin sensitivity in mice through the modulation of mitochondrial homeostasis

High Glucose Induces Cardiac Insulin-Like Growth Factor I Resistance in Ventricular Myocytes: Role of Akt and ERK Activation

Letter: An In Vitro Model to Probe the Regulation of Adipocyte Differentiation under Hyperglycemia (Diabetes Metab J 2013;37:176-80)

Impact of glucotoxicity on TC1-6 cell glucagon secretion

High glucose induces alternative activation of macrophages via PI3K/Akt signaling pathway

Myricetin Attenuates Hyperinsulinemia-Induced Insulin Resistance in Skeletal Muscle Cells

Alpha 2-Heremans Schmid Glycoprotein, A Putative Inhibitor Of Tyrosine Kinase, Prevents Glucose Toxicity Associated With Cardiomyocyte Dysfunction